A Study of AWT020 in Participants With Advanced Solid Tumors

Part of paid clinical trials in Plantation, Florida.

Sponsor
Anwita Biosciences
Study ID
NCT07822919
Phase
PHASE1
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Advanced Cancers (Solid Tumors)

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • AWT020 — BIOLOGICAL
    Participants receiving AWT020 once every three weeks at designated dose levels

Study Details

This study is aimed at establishing the MTD and/or the RP2D for AWT020 monotherapy and to provide safety, tolerability, efficacy, PK, immunogenicity characteristics of AWT020.

Key Dates

First listed
Sep 16, 2026
Start date
Sep 11, 2026
Status verified
Sep 2026
Primary completion
Jan 31, 2029
Completion
Feb 28, 2029

Study Design

Enrollment
96 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: AWT020
    Participants receiving intravenous infusion of AWT020

Primary Outcome Measure

Adverse Events (AEs) [Safety] [ Time Frame: Throughout the study up to 30 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Florida Clinical Trials GroupPlantationFlorida33322
Spencer Herard
[email protected]
773-297-3057
Harshad Amin, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Plantation, FL

By research site
Florida Clinical Trials Group· Plantation, FL